Drug news
Architect HbA1c test to diagnose Diabetes receives 510(k) approval in US - Abbott Diagnostics
Abbott has announced that its new ARCHITECT Clinical Chemistry Hemoglobin A1c (HbA1c) test � which can aid physicians in diagnosing and monitoring Diabetes and identifying people at risk for the disease � has received 510(k) clearance from the FDA.
The clinical chemistry Hemoglobin A1c (HbA1c) test already has CE Mark conformity.
Learning Zones
The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.